A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants

NCT02625259 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm, Advanced or Metastatic

Interventions

DRUG: TAK-117
DRUG: Lansoprazole
DRUG: TAK-117

Sponsor

Millennium Pharmaceuticals, Inc.